NEW YORK (GenomeWeb News) — Decode Genetics has netted $18.4 million after selling and leasing back its Chicago-area medicinal chemistry facility, the company said today.
 
The company sold the Woodridge, Ill., facility for $25 million and leased the space back for a 17-year term, Decode said.
 
Decode said it plans to use the cash it made on the deal to fund its drug- and diagnostic-development programs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.